Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study
<h4>Background</h4> In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have been used after the vaccination campaign started on December 27, 2020. Vaccination of the elderly and chronically ill was prioritized and the interval between doses set to 12 weeks. The objective...
Main Authors: | Ulrike Baum, Eero Poukka, Arto A. Palmu, Heini Salo, Toni O. Lehtonen, Tuija Leino |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601574/?tool=EBI |
Similar Items
-
High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
by: Ulrike Baum, et al.
Published: (2022-11-01) -
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
by: Nina Ekström, et al.
Published: (2024-02-01) -
Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants.
by: Tuija Leino, et al.
Published: (2016-01-01) -
Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial
by: Palmu Arto AI, et al.
Published: (2005-05-01) -
Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics
by: Heta Nieminen, et al.
Published: (2022-01-01)